Lloyd Mitchell Segal - May 18, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
President and CEO
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
May 18, 2021
Transactions value $
-$196,228
Form type
4
Date filed
5/20/2021, 06:19 PM
Next filing
May 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Stock Sale -$63K -1.8K -1.26% $35.00 141K May 18, 2021 See Footnote F1, F2
transaction RPTX Common Stock Sale -$133K -3.8K -2.69% $35.06 137K May 19, 2021 See Footnote F1, F2, F3
holding RPTX Common Stock 5K May 18, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
F2 These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.25, inclusive.